Similar articles for PMID: 1992020

Year	Number of Results
1981	2
1984	1
1986	1
1988	2
1989	15
1990	12
1991	22
1992	26
1993	32
1994	29
1995	15
1996	25
1997	14
1998	1
1999	1
2000	3
2001	2
2002	1
2003	2
2005	1
2006	2
2008	1
2011	1
2014	1
2017	1
2018	1
2020	1
2021	1
2022	0

1

Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.

Woods SW, Hegeman IM, Zubal IG, Krystal JH, Koster K, Smith EO, Heninger GR, Hoffer PB. Woods SW, et al. J Nucl Med. 1991 Feb;32(2):210-5. J Nucl Med. 1991. PMID: 1992020 Free article.

2

Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.

Payne JK, Trivedi MH, Devous MD Sr. Payne JK, et al. J Nucl Med. 1996 Oct;37(10):1735-40. J Nucl Med. 1996. PMID: 8862321 Free article.

3

Baseline, visual deprivation and visual stimulation 99TCm-HMPAO-related changes in visual cortex can be detected with a single-head SPET system.

Catafau AM, Parellada E, Lomeña F, Bernardo M, Pavía J, Ros D, Setoain J. Catafau AM, et al. Nucl Med Commun. 1996 Jun;17(6):480-4. doi: 10.1097/00006231-199606000-00005. Nucl Med Commun. 1996. PMID: 8822745 Clinical Trial.

4

99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.

Andersen AR. Andersen AR. Cerebrovasc Brain Metab Rev. 1989 Winter;1(4):288-318. Cerebrovasc Brain Metab Rev. 1989. PMID: 2701656 Review.

5

SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.

Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H. Koyama M, et al. J Nucl Med. 1997 Apr;38(4):587-92. J Nucl Med. 1997. PMID: 9098207 Free article.

6

Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.

Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I. Rubin RT, et al. Arch Gen Psychiatry. 1992 Sep;49(9):695-702. doi: 10.1001/archpsyc.1992.01820090023004. Arch Gen Psychiatry. 1992. PMID: 1514874

7

An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography.

Pupi A, De Cristofaro MT, Bacciottini L, Antoniucci D, Formiconi AR, Mascalchi M, Meldolesi U. Pupi A, et al. J Nucl Med. 1991 Aug;32(8):1501-6. J Nucl Med. 1991. PMID: 1869968 Free article.

8

Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT.

Murase K, Tanada S, Fujita H, Sakaki S, Hamamoto K. Murase K, et al. J Nucl Med. 1992 Jan;33(1):135-43. J Nucl Med. 1992. PMID: 1730979 Free article.

9

Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.

Léveillé J, Demonceau G, Walovitch RC. Léveillé J, et al. J Nucl Med. 1992 Apr;33(4):480-4. J Nucl Med. 1992. PMID: 1552328 Free article.

10

Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.

Heiss WD, Herholz K, Podreka I, Neubauer I, Pietrzyk U. Heiss WD, et al. J Cereb Blood Flow Metab. 1990 Sep;10(5):687-97. doi: 10.1038/jcbfm.1990.122. J Cereb Blood Flow Metab. 1990. PMID: 2384541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed